Oculis Holding AG
F:CR5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oculis Holding AG
F:CR5
|
CH |
|
Wacker Neuson SE
F:WAC
|
DE |
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
Compagnie Generale des Etablissements Michelin SCA
F:MCHA
|
FR |
|
L'Oreal SA
PAR:OR
|
FR |
|
Gimv NV
F:GI3
|
BE |
|
H
|
Home Depot Inc
XHAM:HDI
|
US |
|
S
|
Salesforce Inc
XMUN:FOO
|
US |
|
DRDGOLD Ltd
F:DUBA
|
ZA |
|
Oversea-Chinese Banking Corporation Ltd
OTC:OVCHF
|
SG |
|
W
|
Western Union Co
BMV:WU
|
US |
|
S
|
Secom Co Ltd
OTC:SOMLF
|
JP |
|
BOK Financial Corp
F:BJR
|
US |
|
I
|
Indocement Tunggal Prakarsa Tbk PT
XBER:ITP
|
ID |
|
Compagnie Generale des Etablissements Michelin SCA
PAR:ML
|
FR |
|
Grupo Famsa SAB de CV
F:4FP
|
MX |
|
S
|
Smurfit Kappa Group PLC
F:SK3
|
IE |
|
Telkom Indonesia (Persero) Tbk PT
F:PTI
|
ID |
|
Fujitsu General Ltd
OTC:FGELF
|
JP |
|
S
|
Sarepta Therapeutics Inc
SWB:AB3A
|
US |
|
P
|
Panoro Minerals Ltd
XMUN:PZM
|
CA |
|
I
|
Itochu Corp
F:IOC
|
JP |
Bankruptcy Probability
Oculis Holding AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oculis Holding AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
O
|
Oculis Holding AG
NASDAQ:OCS
|
1.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oculis Holding AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oculis Holding AG has total debt of 1.8m CHF. This includes both short-term (0 CHF) and long-term (1.8m CHF) debt.
You can find a full breakdown on its Balance Sheet.
